With the mapping of the human genome opening the door to new possibilities for curing diseases and developing medicine, many Japanese companies are running to catch the bandwagon for the emerging biotech business.
In April, Dragon Genomics Co. launched what is touted as Asia's largest private genome analysis center in Yokkaichi, Mie Prefecture.
Equipped with supercomputers and cutting-edge machines to decode DNA sequences, the company claims that the center's capability matches Celera Genomics Corp. of the U.S.